NEW YORK (GenomeWeb News) – Millipore will be the worldwide distributor of the ACTCellerate human progenitor cell lines under a co-marketing agreement signed with BioTime subsidiary Embryome Sciences, BioTime said yesterday.

The ACTCellerate line is derived from human embryonic stem cells but not fully differentiated into specific cell types and are used in drug discovery, research, and development. BioTime said that the cell lines are generated using a two-step multiplex process that rapidly isolates and purifies progenitor cells from different lineages.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.